First Trust Advisors
MRVI icon

First Trust Advisors’s Maravai LifeSciences MRVI Stock Holding History

First Trust Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,399,139
Closed -$20.8M – 2388
2024
Q1 		$20.8M Buy
2,399,139
+877,893
+58% +$5.94M 0.02% 785
2023
Q4 		$9.96M Sell
1,521,246
-324,084
-18% -$2.09M 0.01% 1000
2023
Q3 		$18.5M Buy
+1,845,330
New +$20.3M 0.02% 766
2023
Q1 		– Sell
-233,355
Closed -$3.34M – 2432
2022
Q4 		$3.34M Sell
233,355
-25,906
-10% -$408K ﹤0.01% 1448
2022
Q3 		$6.62M Buy
259,261
+32,594
+14% +$818K 0.01% 1084
2022
Q2 		$6.44M Sell
226,667
-281,646
-55% -$8.92M 0.01% 1107
2022
Q1 		$17.9M Buy
508,313
+320,994
+171% +$10.8M 0.02% 846
2021
Q4 		$7.85M Buy
187,319
+94,841
+103% +$3.84M 0.01% 1158
2021
Q3 		$4.54M Sell
92,478
-173,127
-65% -$8.44M ﹤0.01% 1384
2021
Q2 		$11.1M Buy
265,605
+138,030
+108% +$5.35M 0.01% 975
2021
Q1 		$4.55M Buy
+127,575
New +$4.23M 0.01% 1304

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

First Trust Advisors's MRVI Position: Q2 2024 in Review

First Trust Advisors sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 2,399,139 shares — an estimated $20.8M sold.

First Trust Advisors first reported a position in MRVI in Q1 2021 and held it in 11 quarters. The position peaked at $20.8M in Q1 2024. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

  • First Trust Advisors reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
  • First Trust Advisors sold 2,399,139 Maravai LifeSciences shares in Q2 2024, an estimated $20.8M.
  • First Trust Advisors first reported a position in Maravai LifeSciences in Q1 2021 and held it in 11 quarters.
  • First Trust Advisors's Maravai LifeSciences position peaked at $20.8M in Q1 2024.
  • 206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on First Trust Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.